Marissa Ehringer
Concepts (373)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 25 | 2025 | 344 | 6.690 |
Why?
| | Polymorphism, Single Nucleotide | 37 | 2025 | 2146 | 4.590 |
Why?
| | Smoking | 23 | 2025 | 1579 | 2.720 |
Why?
| | Alcohol Drinking | 16 | 2023 | 849 | 2.700 |
Why?
| | Tobacco Use Disorder | 12 | 2019 | 237 | 2.340 |
Why?
| | Alcoholism | 14 | 2023 | 834 | 2.220 |
Why?
| | Nerve Tissue Proteins | 11 | 2021 | 607 | 1.990 |
Why?
| | Anxiety | 5 | 2023 | 1087 | 1.750 |
Why?
| | Genetic Predisposition to Disease | 18 | 2025 | 2388 | 1.710 |
Why?
| | Motor Activity | 6 | 2021 | 717 | 1.590 |
Why?
| | Genome-Wide Association Study | 14 | 2024 | 1426 | 1.530 |
Why?
| | Ethanol | 10 | 2017 | 637 | 1.410 |
Why?
| | Nicotine | 6 | 2025 | 340 | 1.120 |
Why?
| | Multigene Family | 4 | 2013 | 204 | 1.080 |
Why?
| | Genotype | 15 | 2020 | 1866 | 1.020 |
Why?
| | Conduct Disorder | 5 | 2014 | 188 | 0.980 |
Why?
| | Behavior, Animal | 5 | 2023 | 515 | 0.960 |
Why?
| | Phenotype | 18 | 2023 | 3184 | 0.910 |
Why?
| | Mice, Inbred Strains | 5 | 2023 | 404 | 0.900 |
Why?
| | Brain | 7 | 2023 | 2875 | 0.880 |
Why?
| | Central Nervous System Depressants | 3 | 2014 | 89 | 0.860 |
Why?
| | Physical Conditioning, Animal | 2 | 2018 | 246 | 0.830 |
Why?
| | Diazepam | 1 | 2023 | 35 | 0.810 |
Why?
| | Genetic Markers | 3 | 2020 | 343 | 0.810 |
Why?
| | Anti-Anxiety Agents | 1 | 2023 | 43 | 0.790 |
Why?
| | Receptors, GABA-A | 3 | 2016 | 141 | 0.770 |
Why?
| | Tobacco Products | 1 | 2024 | 91 | 0.770 |
Why?
| | Cultural Diversity | 1 | 2023 | 87 | 0.750 |
Why?
| | Gene Frequency | 7 | 2016 | 490 | 0.710 |
Why?
| | Genetic Variation | 6 | 2022 | 999 | 0.700 |
Why?
| | Substance-Related Disorders | 9 | 2015 | 1107 | 0.670 |
Why?
| | Choice Behavior | 3 | 2017 | 172 | 0.650 |
Why?
| | Locomotion | 1 | 2021 | 106 | 0.640 |
Why?
| | Haplotypes | 7 | 2015 | 491 | 0.640 |
Why?
| | Marijuana Abuse | 5 | 2012 | 232 | 0.630 |
Why?
| | Genetic Association Studies | 4 | 2016 | 375 | 0.630 |
Why?
| | Nicotinic Agonists | 2 | 2025 | 136 | 0.620 |
Why?
| | Behavior, Addictive | 1 | 2020 | 89 | 0.610 |
Why?
| | Chromosome Mapping | 6 | 2020 | 502 | 0.610 |
Why?
| | Transcriptome | 5 | 2023 | 1015 | 0.590 |
Why?
| | Opioid-Related Disorders | 2 | 2024 | 574 | 0.580 |
Why?
| | Students | 1 | 2023 | 646 | 0.540 |
Why?
| | Female | 53 | 2025 | 76624 | 0.540 |
Why?
| | Alleles | 5 | 2015 | 885 | 0.530 |
Why?
| | Human Genetics | 1 | 2017 | 3 | 0.530 |
Why?
| | Parkinson Disease | 1 | 2024 | 574 | 0.530 |
Why?
| | Biomedical Research | 1 | 2023 | 692 | 0.520 |
Why?
| | Animals | 28 | 2025 | 37697 | 0.520 |
Why?
| | Humans | 70 | 2025 | 142526 | 0.510 |
Why?
| | Siblings | 9 | 2011 | 217 | 0.510 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2025 | 676 | 0.510 |
Why?
| | Sex Characteristics | 4 | 2020 | 790 | 0.510 |
Why?
| | Male | 54 | 2025 | 70910 | 0.500 |
Why?
| | Mice | 20 | 2025 | 18172 | 0.500 |
Why?
| | Age of Onset | 7 | 2021 | 545 | 0.490 |
Why?
| | Hippocampus | 3 | 2022 | 944 | 0.490 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2016 | 38 | 0.490 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2014 | 142 | 0.480 |
Why?
| | Gene Regulatory Networks | 3 | 2023 | 315 | 0.470 |
Why?
| | Microbiota | 1 | 2023 | 756 | 0.470 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 727 | 0.470 |
Why?
| | Quantitative Trait Loci | 3 | 2020 | 366 | 0.470 |
Why?
| | Gene Expression Regulation | 3 | 2013 | 2608 | 0.470 |
Why?
| | Physical Exertion | 1 | 2016 | 209 | 0.450 |
Why?
| | Running | 3 | 2016 | 229 | 0.450 |
Why?
| | Neurogenesis | 2 | 2015 | 154 | 0.440 |
Why?
| | Anxiety Disorders | 4 | 2023 | 371 | 0.440 |
Why?
| | Mice, Inbred C57BL | 11 | 2025 | 5967 | 0.430 |
Why?
| | Corpus Striatum | 1 | 2016 | 178 | 0.430 |
Why?
| | Taste Perception | 1 | 2014 | 31 | 0.430 |
Why?
| | Adolescent | 34 | 2016 | 22326 | 0.420 |
Why?
| | DNA, Intergenic | 1 | 2013 | 29 | 0.400 |
Why?
| | Genetic Testing | 1 | 2016 | 468 | 0.400 |
Why?
| | Receptors, Opioid, mu | 4 | 2019 | 70 | 0.390 |
Why?
| | Mothers | 1 | 2019 | 781 | 0.390 |
Why?
| | Social Environment | 5 | 2007 | 294 | 0.380 |
Why?
| | Longitudinal Studies | 11 | 2019 | 2980 | 0.380 |
Why?
| | Neurons | 2 | 2020 | 1626 | 0.380 |
Why?
| | Child Behavior Disorders | 2 | 2011 | 143 | 0.380 |
Why?
| | Up-Regulation | 1 | 2015 | 857 | 0.380 |
Why?
| | Promoter Regions, Genetic | 3 | 2015 | 1254 | 0.380 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 152 | 0.380 |
Why?
| | Food Preferences | 1 | 2013 | 125 | 0.370 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 21 | 0.360 |
Why?
| | Psychology, Adolescent | 2 | 2009 | 69 | 0.360 |
Why?
| | Gene Expression | 3 | 2015 | 1496 | 0.340 |
Why?
| | Species Specificity | 5 | 2023 | 574 | 0.340 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2025 | 440 | 0.340 |
Why?
| | Mental Disorders | 5 | 2020 | 1144 | 0.340 |
Why?
| | Alcohol-Related Disorders | 2 | 2012 | 127 | 0.320 |
Why?
| | Linkage Disequilibrium | 4 | 2013 | 252 | 0.310 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 6 | 2013 | 240 | 0.300 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2009 | 45 | 0.300 |
Why?
| | Genes, Neoplasm | 1 | 2008 | 24 | 0.290 |
Why?
| | Antisocial Personality Disorder | 4 | 2016 | 153 | 0.290 |
Why?
| | Luciferases | 3 | 2013 | 149 | 0.280 |
Why?
| | Internationality | 2 | 2022 | 156 | 0.280 |
Why?
| | Exercise | 1 | 2020 | 2133 | 0.270 |
Why?
| | Mice, Knockout | 6 | 2025 | 3081 | 0.270 |
Why?
| | Case-Control Studies | 9 | 2019 | 3604 | 0.260 |
Why?
| | Mice, 129 Strain | 2 | 2018 | 86 | 0.260 |
Why?
| | Receptors, Cannabinoid | 1 | 2006 | 15 | 0.260 |
Why?
| | Impulsive Behavior | 2 | 2007 | 150 | 0.250 |
Why?
| | Adult | 28 | 2025 | 39715 | 0.250 |
Why?
| | United Kingdom | 2 | 2025 | 325 | 0.250 |
Why?
| | Polymorphism, Genetic | 5 | 2013 | 622 | 0.240 |
Why?
| | Protein Kinase C | 1 | 2007 | 252 | 0.240 |
Why?
| | Exploratory Behavior | 2 | 2021 | 89 | 0.230 |
Why?
| | Colorado | 7 | 2020 | 4638 | 0.220 |
Why?
| | Analgesics, Opioid | 3 | 2024 | 1123 | 0.220 |
Why?
| | Infant, Low Birth Weight | 1 | 2025 | 148 | 0.220 |
Why?
| | Multifactorial Inheritance | 2 | 2023 | 190 | 0.220 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2024 | 16 | 0.210 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2024 | 53 | 0.210 |
Why?
| | Sex Factors | 4 | 2020 | 2074 | 0.210 |
Why?
| | Interdisciplinary Research | 1 | 2023 | 26 | 0.200 |
Why?
| | Astrocytes | 1 | 2025 | 217 | 0.200 |
Why?
| | Disease Models, Animal | 3 | 2023 | 4483 | 0.200 |
Why?
| | Analgesia | 1 | 2024 | 104 | 0.200 |
Why?
| | Epistasis, Genetic | 1 | 2023 | 67 | 0.190 |
Why?
| | Young Adult | 10 | 2016 | 13878 | 0.190 |
Why?
| | Analysis of Variance | 2 | 2017 | 1313 | 0.190 |
Why?
| | Hypnotics and Sedatives | 2 | 2017 | 217 | 0.190 |
Why?
| | Family | 4 | 2011 | 682 | 0.190 |
Why?
| | Tobacco Use | 1 | 2022 | 65 | 0.180 |
Why?
| | Human Genome Project | 1 | 2002 | 15 | 0.180 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 445 | 0.180 |
Why?
| | Rats | 3 | 2024 | 5585 | 0.170 |
Why?
| | Maze Learning | 1 | 2021 | 104 | 0.170 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 2 | 2014 | 68 | 0.170 |
Why?
| | Spatial Memory | 1 | 2020 | 27 | 0.170 |
Why?
| | Quantitative Trait, Heritable | 1 | 2001 | 124 | 0.160 |
Why?
| | Transfection | 2 | 2013 | 936 | 0.160 |
Why?
| | Extinction, Psychological | 1 | 2020 | 91 | 0.150 |
Why?
| | Polymerase Chain Reaction | 2 | 2014 | 1051 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 985 | 0.150 |
Why?
| | Dizziness | 2 | 2010 | 95 | 0.150 |
Why?
| | RNA, Messenger | 3 | 2014 | 2828 | 0.150 |
Why?
| | Repressor Proteins | 1 | 2002 | 435 | 0.150 |
Why?
| | Computational Biology | 2 | 2020 | 673 | 0.150 |
Why?
| | Epigenomics | 1 | 2019 | 115 | 0.140 |
Why?
| | Lung Neoplasms | 2 | 2010 | 2568 | 0.140 |
Why?
| | Mice, Inbred BALB C | 2 | 2020 | 1267 | 0.140 |
Why?
| | Mice, Inbred C3H | 1 | 2018 | 255 | 0.140 |
Why?
| | Smokers | 1 | 2019 | 146 | 0.140 |
Why?
| | Genetic Loci | 2 | 2022 | 277 | 0.140 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2019 | 1045 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2024 | 1160 | 0.130 |
Why?
| | Calmodulin-Binding Proteins | 1 | 2016 | 13 | 0.120 |
Why?
| | GABA Plasma Membrane Transport Proteins | 1 | 2016 | 7 | 0.120 |
Why?
| | Syntaxin 1 | 1 | 2016 | 14 | 0.120 |
Why?
| | Proprotein Convertases | 1 | 2016 | 16 | 0.120 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2016 | 28 | 0.120 |
Why?
| | Munc18 Proteins | 1 | 2016 | 24 | 0.120 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 3546 | 0.120 |
Why?
| | Brain Chemistry | 2 | 2009 | 115 | 0.120 |
Why?
| | Quality Control | 1 | 2016 | 160 | 0.120 |
Why?
| | Potassium Channels | 1 | 2016 | 144 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2016 | 188 | 0.120 |
Why?
| | Genomics | 1 | 2020 | 820 | 0.110 |
Why?
| | DNA-Binding Proteins | 1 | 2002 | 1500 | 0.110 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2011 | 437 | 0.110 |
Why?
| | Sleep | 3 | 2013 | 889 | 0.110 |
Why?
| | Interviews as Topic | 3 | 2007 | 857 | 0.110 |
Why?
| | Volition | 1 | 2014 | 34 | 0.110 |
Why?
| | Body Temperature | 1 | 2015 | 224 | 0.110 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 677 | 0.110 |
Why?
| | Saccharin | 1 | 2013 | 8 | 0.100 |
Why?
| | Vesicular Monoamine Transport Proteins | 1 | 2013 | 8 | 0.100 |
Why?
| | Trans-Activators | 1 | 2016 | 401 | 0.100 |
Why?
| | Europe | 3 | 2022 | 410 | 0.100 |
Why?
| | Serotonin | 2 | 2008 | 290 | 0.100 |
Why?
| | Cotinine | 1 | 2013 | 78 | 0.100 |
Why?
| | Age Factors | 3 | 2017 | 3316 | 0.100 |
Why?
| | Base Sequence | 4 | 2013 | 2176 | 0.100 |
Why?
| | Sweetening Agents | 1 | 2013 | 55 | 0.100 |
Why?
| | Schizophrenia | 1 | 2017 | 441 | 0.100 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2013 | 86 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2016 | 440 | 0.100 |
Why?
| | HEK293 Cells | 1 | 2015 | 747 | 0.100 |
Why?
| | Adolescent Behavior | 3 | 2014 | 541 | 0.090 |
Why?
| | Reflex, Righting | 1 | 2012 | 15 | 0.090 |
Why?
| | Inhalant Abuse | 1 | 2012 | 3 | 0.090 |
Why?
| | Aging | 2 | 2022 | 1931 | 0.090 |
Why?
| | Tobacco Smoking | 2 | 2023 | 25 | 0.090 |
Why?
| | Twins | 3 | 2010 | 225 | 0.090 |
Why?
| | Peer Group | 1 | 2014 | 250 | 0.090 |
Why?
| | Twins, Monozygotic | 3 | 2011 | 191 | 0.090 |
Why?
| | Pedigree | 1 | 2013 | 507 | 0.090 |
Why?
| | Comorbidity | 4 | 2011 | 1678 | 0.090 |
Why?
| | Reward | 1 | 2013 | 252 | 0.090 |
Why?
| | Residence Characteristics | 1 | 2014 | 372 | 0.080 |
Why?
| | Pregnancy | 2 | 2025 | 7113 | 0.080 |
Why?
| | Genetic Linkage | 2 | 2008 | 288 | 0.080 |
Why?
| | Research Design | 1 | 2017 | 1113 | 0.080 |
Why?
| | Software | 1 | 2016 | 682 | 0.080 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2010 | 53 | 0.080 |
Why?
| | Cells, Cultured | 2 | 2025 | 4167 | 0.080 |
Why?
| | Models, Genetic | 2 | 2010 | 587 | 0.080 |
Why?
| | Factor Analysis, Statistical | 2 | 2010 | 299 | 0.080 |
Why?
| | Middle Aged | 7 | 2022 | 35049 | 0.080 |
Why?
| | Prevalence | 4 | 2019 | 2817 | 0.080 |
Why?
| | Darkness | 1 | 2009 | 26 | 0.080 |
Why?
| | Nuclear Family | 1 | 2009 | 56 | 0.080 |
Why?
| | Data Interpretation, Statistical | 2 | 2010 | 374 | 0.080 |
Why?
| | Plasmids | 1 | 2010 | 369 | 0.080 |
Why?
| | Alcohol-Induced Disorders, Nervous System | 1 | 2009 | 6 | 0.080 |
Why?
| | Sample Size | 2 | 2022 | 126 | 0.080 |
Why?
| | Socioeconomic Factors | 2 | 2010 | 1319 | 0.070 |
Why?
| | Survival Analysis | 1 | 2012 | 1328 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 527 | 0.070 |
Why?
| | Receptors, Dopamine D2 | 2 | 2006 | 96 | 0.070 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 11 | 0.070 |
Why?
| | Cell Line | 1 | 2013 | 2878 | 0.070 |
Why?
| | United States | 6 | 2019 | 15447 | 0.070 |
Why?
| | Risk Factors | 3 | 2025 | 10593 | 0.060 |
Why?
| | Eating | 1 | 2009 | 397 | 0.060 |
Why?
| | MicroRNAs | 1 | 2013 | 696 | 0.060 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2008 | 196 | 0.060 |
Why?
| | Emotions | 1 | 2012 | 580 | 0.060 |
Why?
| | DNA | 2 | 2010 | 1447 | 0.060 |
Why?
| | Marijuana Smoking | 1 | 2010 | 262 | 0.060 |
Why?
| | Glutamic Acid | 1 | 2008 | 256 | 0.060 |
Why?
| | Psychology, Child | 1 | 2006 | 39 | 0.060 |
Why?
| | Self Disclosure | 1 | 2006 | 66 | 0.060 |
Why?
| | Receptors, Dopamine D1 | 1 | 2006 | 35 | 0.060 |
Why?
| | Internal-External Control | 1 | 2006 | 77 | 0.060 |
Why?
| | Biometry | 1 | 2006 | 70 | 0.060 |
Why?
| | Data Collection | 1 | 2008 | 655 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 2008 | 0.060 |
Why?
| | Religion | 1 | 2006 | 68 | 0.060 |
Why?
| | Monoamine Oxidase | 1 | 2005 | 28 | 0.060 |
Why?
| | Dopamine | 1 | 2008 | 305 | 0.060 |
Why?
| | Linear Models | 1 | 2007 | 857 | 0.060 |
Why?
| | Infant | 1 | 2019 | 9908 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 112 | 0.060 |
Why?
| | Cannabis | 1 | 2012 | 518 | 0.050 |
Why?
| | Smoking Cessation | 1 | 2008 | 434 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 1284 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2008 | 759 | 0.050 |
Why?
| | Oxycodone | 1 | 2024 | 48 | 0.050 |
Why?
| | Child | 6 | 2015 | 22562 | 0.050 |
Why?
| | RNA | 1 | 2010 | 929 | 0.050 |
Why?
| | Motivation | 1 | 2008 | 606 | 0.050 |
Why?
| | Receptors, Opioid, kappa | 1 | 2003 | 9 | 0.050 |
Why?
| | Cohort Studies | 2 | 2015 | 5858 | 0.050 |
Why?
| | Mice, Congenic | 1 | 2002 | 23 | 0.050 |
Why?
| | Sequence Analysis, Protein | 1 | 2002 | 33 | 0.050 |
Why?
| | Sampling Studies | 1 | 2002 | 103 | 0.050 |
Why?
| | Avoidance Learning | 1 | 2003 | 73 | 0.050 |
Why?
| | Ataxia | 1 | 2002 | 70 | 0.050 |
Why?
| | Birth Weight | 1 | 2025 | 517 | 0.050 |
Why?
| | Open Reading Frames | 1 | 2002 | 133 | 0.050 |
Why?
| | Gene-Environment Interaction | 2 | 2014 | 190 | 0.040 |
Why?
| | Cyclic AMP | 1 | 2002 | 215 | 0.040 |
Why?
| | Gene Silencing | 1 | 2002 | 199 | 0.040 |
Why?
| | Exons | 1 | 2002 | 352 | 0.040 |
Why?
| | Phylogeny | 3 | 2000 | 1003 | 0.040 |
Why?
| | Psychopathology | 1 | 2021 | 58 | 0.040 |
Why?
| | Memory, Long-Term | 1 | 2020 | 12 | 0.040 |
Why?
| | Nucleic Acid Hybridization | 1 | 2001 | 189 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2001 | 305 | 0.040 |
Why?
| | Spatial Behavior | 1 | 2020 | 26 | 0.040 |
Why?
| | Ascomycota | 1 | 2000 | 28 | 0.040 |
Why?
| | Eukaryotic Cells | 1 | 2000 | 40 | 0.040 |
Why?
| | Interleukins | 1 | 2022 | 252 | 0.040 |
Why?
| | Crenarchaeota | 1 | 2000 | 3 | 0.040 |
Why?
| | Endoribonucleases | 1 | 2000 | 79 | 0.040 |
Why?
| | Fungal Proteins | 1 | 2000 | 139 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2022 | 417 | 0.040 |
Why?
| | RNA, Catalytic | 1 | 2000 | 189 | 0.040 |
Why?
| | rab4 GTP-Binding Proteins | 1 | 2019 | 8 | 0.040 |
Why?
| | Cytochrome P-450 CYP2B6 | 1 | 2019 | 10 | 0.040 |
Why?
| | Cytochrome P450 Family 2 | 1 | 2019 | 12 | 0.040 |
Why?
| | Child Abuse | 1 | 2005 | 549 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2020 | 400 | 0.040 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2019 | 47 | 0.040 |
Why?
| | Archaea | 1 | 2000 | 84 | 0.040 |
Why?
| | Twins, Dizygotic | 2 | 2011 | 163 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2022 | 970 | 0.030 |
Why?
| | Inflammation | 2 | 2022 | 2867 | 0.030 |
Why?
| | Aged | 4 | 2022 | 25117 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2010 | 553 | 0.030 |
Why?
| | Picrates | 1 | 1996 | 5 | 0.030 |
Why?
| | Risk | 1 | 2019 | 905 | 0.030 |
Why?
| | Gram-Positive Bacteria | 1 | 1996 | 48 | 0.030 |
Why?
| | Surveys and Questionnaires | 4 | 2012 | 5994 | 0.030 |
Why?
| | Southeastern United States | 1 | 2014 | 36 | 0.030 |
Why?
| | Alcoholics | 1 | 2013 | 2 | 0.030 |
Why?
| | Transcription, Genetic | 2 | 2013 | 1498 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2025 | 6324 | 0.030 |
Why?
| | Gene Ontology | 1 | 2013 | 51 | 0.030 |
Why?
| | Enkephalins | 1 | 2013 | 19 | 0.020 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 9 | 0.020 |
Why?
| | Prealbumin | 1 | 2013 | 35 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2002 | 5270 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2019 | 8020 | 0.020 |
Why?
| | Mice, Inbred DBA | 2 | 2003 | 200 | 0.020 |
Why?
| | Myosins | 1 | 2013 | 137 | 0.020 |
Why?
| | Protein Precursors | 1 | 2013 | 134 | 0.020 |
Why?
| | Severity of Illness Index | 2 | 2012 | 2927 | 0.020 |
Why?
| | Exome | 1 | 2013 | 236 | 0.020 |
Why?
| | Adolescent Development | 1 | 2012 | 89 | 0.020 |
Why?
| | DNA, Complementary | 2 | 2002 | 275 | 0.020 |
Why?
| | Molecular Sequence Data | 3 | 2003 | 2916 | 0.020 |
Why?
| | Anxiety, Separation | 1 | 2011 | 16 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 432 | 0.020 |
Why?
| | Pleasure | 1 | 2010 | 18 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 327 | 0.020 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2011 | 62 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4112 | 0.020 |
Why?
| | Sensation | 1 | 2010 | 56 | 0.020 |
Why?
| | Interview, Psychological | 1 | 2010 | 97 | 0.020 |
Why?
| | NF-kappa B | 1 | 2013 | 684 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1013 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2013 | 546 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3362 | 0.020 |
Why?
| | Psychological Tests | 1 | 2010 | 133 | 0.020 |
Why?
| | Models, Psychological | 1 | 2011 | 313 | 0.020 |
Why?
| | Signal Transduction | 1 | 2002 | 5163 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 2007 | 90 | 0.020 |
Why?
| | Juvenile Delinquency | 1 | 2007 | 106 | 0.020 |
Why?
| | Cheek | 1 | 2006 | 17 | 0.020 |
Why?
| | Hypoxia | 1 | 2013 | 1166 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1773 | 0.010 |
Why?
| | Genome, Human | 1 | 2008 | 425 | 0.010 |
Why?
| | Environment | 1 | 2007 | 343 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2006 | 330 | 0.010 |
Why?
| | Taq Polymerase | 1 | 2004 | 10 | 0.010 |
Why?
| | Logistic Models | 1 | 2010 | 2102 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2081 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 154 | 0.010 |
Why?
| | Child Behavior | 1 | 2005 | 252 | 0.010 |
Why?
| | Colforsin | 1 | 2002 | 48 | 0.010 |
Why?
| | Isoproterenol | 1 | 2002 | 101 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2002 | 105 | 0.010 |
Why?
| | Adrenergic beta-Agonists | 1 | 2002 | 97 | 0.010 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 145 | 0.010 |
Why?
| | Genes, Tumor Suppressor | 1 | 2001 | 85 | 0.010 |
Why?
| | Ribonuclease P | 1 | 2000 | 22 | 0.010 |
Why?
| | Antigens, Surface | 1 | 2001 | 156 | 0.010 |
Why?
| | Consensus Sequence | 1 | 2000 | 74 | 0.010 |
Why?
| | Genes, Fungal | 1 | 2000 | 51 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2010 | 16626 | 0.010 |
Why?
| | Enzymes | 1 | 2001 | 65 | 0.010 |
Why?
| | Ion Channels | 1 | 2001 | 130 | 0.010 |
Why?
| | Oncogenes | 1 | 2001 | 119 | 0.010 |
Why?
| | DNA, Fungal | 1 | 2000 | 81 | 0.010 |
Why?
| | Wyoming | 1 | 2000 | 27 | 0.010 |
Why?
| | DNA, Archaeal | 1 | 2000 | 17 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2000 | 365 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2000 | 224 | 0.010 |
Why?
| | Blotting, Western | 1 | 2002 | 1220 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2000 | 573 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 319 | 0.010 |
Why?
| | Postural Balance | 1 | 2002 | 241 | 0.010 |
Why?
| | Alternative Splicing | 1 | 2001 | 238 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2000 | 333 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2000 | 416 | 0.010 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2000 | 548 | 0.010 |
Why?
| | Nucleic Acid Conformation | 1 | 2000 | 726 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2002 | 2180 | 0.010 |
Why?
| | Temperature | 1 | 2000 | 672 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2000 | 820 | 0.010 |
Why?
| | Evolution, Molecular | 1 | 2000 | 504 | 0.010 |
Why?
| | Industrial Waste | 1 | 1996 | 6 | 0.010 |
Why?
| | Zebrafish | 1 | 2000 | 509 | 0.010 |
Why?
| | Biodegradation, Environmental | 1 | 1996 | 87 | 0.010 |
Why?
| | Biological Evolution | 1 | 2000 | 488 | 0.010 |
Why?
| | Transcription Factors | 1 | 2001 | 1728 | 0.010 |
Why?
| | Fatty Acids | 1 | 1996 | 449 | 0.010 |
Why?
| | Time Factors | 1 | 2001 | 7006 | 0.000 |
Why?
| | Mutation | 1 | 2000 | 4024 | 0.000 |
Why?
|
|
Ehringer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|